BB&T Securities’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$723K Buy
2,651
+156
+6% +$43.4K 0.01% 944
2019
Q2
$686K Buy
2,495
+703
+39% +$173K 0.01% 967
2019
Q1
$400K Buy
1,792
+568
+46% +$117K ﹤0.01% 1174
2018
Q4
$227K Buy
1,224
+2
+0.2% +$410 ﹤0.01% 1313
2018
Q3
$305K Buy
1,222
+20
+2% +$4.86K ﹤0.01% 1315
2018
Q2
$261K Hold
1,202
﹤0.01% 1336
2018
Q1
$230K Buy
+1,202
New +$222K ﹤0.01% 1336
2017
Q4
Sell
-1,371
Closed -$213K 1481
2017
Q3
$213K Buy
+1,371
New +$217K ﹤0.01% 1275
2016
Q3
Sell
-2,845
Closed -$264K 1241
2016
Q2
$264K Sell
2,845
-3,822
-57% -$328K ﹤0.01% 1033
2016
Q1
$522K Sell
6,667
-619
-8% -$44.6K 0.01% 757
2015
Q4
$531K Buy
7,286
+3,335
+84% +$238K 0.01% 701
2015
Q3
$293K Buy
+3,951
New +$283K 0.01% 876
2013
Q4
Sell
-14,510
Closed -$723K 904
2013
Q3
$723K Buy
14,510
+1,490
+11% +$71.6K 0.02% 431
2013
Q2
$584K Buy
+13,020
New +$569K 0.02% 463

Other funds holding IDXX

BB&T Securities's IDXX Position: Q3 2019 in Review

BB&T Securities increased its Idexx Laboratories (IDXX) stake by 6.3% in Q3 2019, buying an estimated $43.4K and bringing the position to 2,651 shares worth $723K. The position accounts for 0.01% of the portfolio, ranked #944.

BB&T Securities first reported a position in IDXX in Q2 2013 and has held it in 14 quarters since. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

  • BB&T Securities held 2,651 shares of Idexx Laboratories worth $723K as of Q3 2019.
  • BB&T Securities bought 156 Idexx Laboratories shares in Q3 2019, an estimated $43.4K.
  • Idexx Laboratories made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #944 holding.
  • BB&T Securities first reported a position in Idexx Laboratories in Q2 2013 and has held it in 14 quarters since.
  • 720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.